Dr. Rupa Haldavnekar has received PhD in Biomedical engineering from Toronto metropolitan University. She did her postdoctoral fellowship at Micheal Smith laboratory, University of British Columbia prior to starting her academic journey at McGill University in Montreal, Canada. She also holds Bachelor of Engineering in Mechanical Engineering and Master of Business Administration degrees.
Dr. Haldavnekar’s research focuses on developing innovative technologies for early cancer diagnosis, biomarker discovery, and real-time treatment monitoring. Her work integrates nanotechnology, Raman and surface-enhanced Raman spectroscopy (SERS), and machine learning to create highly sensitive, data-driven liquid biopsy platforms for noninvasive disease detection.
Dr. Haldavnekar collaborates with a multidisciplinary team of researchers, engineers, and clinicians to design rapid and scalable diagnostic tools that can improve cancer detection and patient monitoring. Her research bridges engineering, nanomaterials, and biomedical sciences, with expertise spanning Raman spectroscopy, SERS-based sensing, and machine learning analysis of liquid biopsy biomarkers.
In addition to her research, Dr. Haldavnekar is a dedicated mentor who actively supports the development of early-career scientists. She fosters a collaborative research environment that encourages curiosity, creativity, and interdisciplinary problem-solving to address complex challenges in healthcare.
